From: Clinical relevance of Neutral Endopeptidase (NEP/CD10) in melanoma
Disease Stage: | Specimens tested (n) | NEP overexpression (n) | NEP overexpression (%) |
---|---|---|---|
Primary | 33 | 1 | 3% |
Metastatic | Â | Â | Â |
   Lymph Node | 27 | 7 | 26% |
   Skin/Subcutaneous | 19 | 6 | 32% |
   Visceral | 8 | 4 | 50% |
   Primary biopsy from metastatic patients | 6 | 1 | 17% |
   Total | 60 | 18 | 30% |